INVO Fertility to Present at Lytham Partners Fall 2026 Investor Conference

  • INVO Fertility will participate in the Lytham Partners Fall 2026 Investor Conference on September 29-30, 2026.
  • The company will host a webcast presentation at 11:30 a.m. ET on September 29, 2026.
  • Management will conduct one-on-one meetings with investors during the event.
  • INVO Fertility operates four fertility clinics in the U.S. and sells the INVOcell device to third-party clinics.

INVO Fertility's participation in the Lytham Partners Fall 2026 Investor Conference underscores its focus on expanding access to assisted reproductive technology (ART) care. The company's dual strategy of operating clinics and selling proprietary technology positions it within a competitive fertility services market. Its ability to scale operations and drive adoption of INVOcell will be key to sustaining growth amid increasing demand for ART solutions.

Strategic Growth
How INVO Fertility's acquisition strategy for U.S.-based, profitable fertility clinics will impact its market position.
Technology Adoption
The pace at which third-party clinics adopt the INVOcell device and its effect on revenue growth.
Investor Sentiment
Whether the company's presentation and one-on-one meetings will shift investor perception of its long-term prospects.